Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle
MedEdTalks - Neurology
English - December 07, 2022 16:54 - 15 minutes - 29.2 MBMedicine Health & Fitness Science brucecohen claireriley clydemarkowith cme multiplesclerosis neurology patriciacoyle Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton’s tyrosine kinase (BTK) inhibitors.